MS Speaks

Multiple Sclerosis => TREATMENTS => Topic started by: agate on October 14, 2020, 09:48:59 pm

Title: Fast tracking AB-555 (elezanumab) fpr SCI, possibly MS
Post by: agate on October 14, 2020, 09:48:59 pm

A short article entitled "AbbVie Gets Orphan Drug and Fast Track Status for Elezanumab" (from Pharmaceutical Technology, 9/29/20).  It is a potential drug for SCI (spinal cord injury) but there is some possibility that it might be useful for treating MS as well. According to the article,

Quote

Studies of elezanumab to treat spinal cord injuries, as well as multiple sclerosis and acute ischemic stroke, are under progress. The drug candidate is undergoing a Phase II clinical trial for SCI.

https://www.pharmaceutical-technology.com/news/abbvie-orphan-drug-elezanumab/